Quantitative analysis of osteonectin mRNA in thyroid carcinomas

Endocrine Journal

Volumn 49, Issue 4, 2002, Pages 511-516

  Takano, Toru ^a   Hasegawa, Yukiko ^a   Miyauchi, Akira ^b   Matsuzuka, Fumio ^b   Yoshida, Hiroshi ^b   Kuma, Kanji ^b   Hayashi, Nobuyasu ^a   Nakamori, Shoji ^a   Amino, Nobuyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KUMA HOSPITAL   (Japan)

Author keywords

Fine needle aspiration biopsy; Osteonectin; Reverse transcription PCR; Thyroid carcinoma

Indexed keywords

MESSENGER RNA; OSTEONECTIN; SCLEROPROTEIN;

ANAPLASTIC CARCINOMA; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; THYROID CARCINOMA;

CARCINOMA; COMPUTER SYSTEMS; HUMANS; OSTEONECTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID GLAND; THYROID NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0036692361     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.49.511     Document Type: Article

References (30)

1. Cancer-specific mRNAs in thyroid carcinomas: Detection, use, and their implication in thyroid carcinogenesis
2. Accurate and objective preoperative diagnosis of thyroid papillary carcinomas by reverse transcription-PCR detection of oncofetal fibronectin messenger RNA in fine-needle aspiration biopsies
3. Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA
4. Preoperative diagnosis of medullary thyroid carcinoma by RT-PCR using RNA extracted from leftover cells within a needle used for fine needle aspiration biopsy
5. Diagnosis of thyroid malignant lymphoma by reverse transcription-polymerase chain reaction detecting the monoclonality of immuno-globulin heavy chain messenger ribonucleic acid
6. Serial analysis of gene expression
7. Gene expression profiles in thyroid carcinomas
8. The biology of SPARC, a protein that modulates cell-matrix interactions
9. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction
10. Establishment of anaplastic thyroid carcinoma cell lines useful for analysis of chemosensitivity and carcinogenesis
11. Comparative genomic hybridization defines frequent loss on 16p in human anaplastic thyroid carcinoma
12. Detection of CD44 variants in fine needle aspiration biopsies of thyroid tumor by RT-PCR
13. Molecular analysis of the cDNA for human SPARC/osteonectin/BM-40: Sequence, expression, and localization of the gene to chromosome 5q31-q33
14. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA
15. Primary structure of human thyroglobulin deduced from the sequence of its 8448-base complementary DNA
16. Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin
17. Terms of attachment: SPARC and tumorigenesis
18. SPARC induces the expression of type 1 plasminogen activator inhibitor in cultured bovine aortic endothelial cells
19. SPARC, a secreted protein associated with morpho-genesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway
20. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells
21. The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma
22. SPARC: A signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas
23. SPARC: A potential diagnostic marker of invasive meningiomas
24. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: Implications for prognosis
25. Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes
26. Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer
27. SPARC expression in primary human renal cell carcinoma: Upregulation of SPARC in sarcomatoid renal carcinoma
28. Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma
29. Distribution of SPARC in normal and neoplastic human tissue
30. Expression of oncofetal fibronectin messenger ribonucleic acid in fibroblasts in the thyroid: A possible cause of false positive results in molecular-based diagnosis of thyroid carcinomas